• Journal of Pharmaceutical Investigation
• /
• 제38권4호
• /
• pp.249-254
• /
• 2008

Solid dispersions of poorly water-soluble drug, atorvastatin, were prepared with Eudragit L100 to improve the solubility by spray dryer. To investigate the correlation between physicochemical properties and dissolution rate of solid dispersions, the samples were characterized by scanning electron microscopy (SEM), differential scanning calorimeter (DSC) and fourier transform infrared spectroscopy (FT-IR). SEM and DSC were found that atorvastatin is amorphous in the Eudragit L100 solid dispersion. FT-IR was used to analyze the salt formation by interaction between atorvastatin and Eudragit L100. The dissolution rate of solid dispersed atorvastatin was markedly increased compared to drug powder in stimulated intestinal juice (pH 6.8). Thus, the solid dispersed atorvastatin using the spray drying method with Eudragit L100 may be effective for the bioavailability.

• Journal of Pharmaceutical Investigation
• /
• 제37권6호
• /
• pp.339-347
• /
• 2007

SMEDDS is mixture of oils, surfactants, and cosurfactants, which are emulsified in aqueous media under conditions of gentle agitation and digestive motility that would be encountered in the gastro-intestinal(GI) tract. The main purpose of this work is to prepare self-microemulsifying drug delivery system(SMEDDS) for oral bioavailability enhancement of a poorly water soluble drug, atorvastatin calcium. Solubility of atorvastatin calcium was determined in various vehicles. Pseudo-ternary phase diagrams were constructed to identity the efficient self-emulsification region and particle size distributions of the resultant micro emulsions were determined using a laser diffraction sizer. Optimized formulations for in vitro dissolution and bioavailability assessment were $Capryol^{(R)}$ 90(50%), Tetraglycol(16%), and $Cremophor^{(R)}$ EL(32%). The release rate of atorvastatin from SMEDDS was significantly higher than the conventional tablet ($Lipitor^{(R)}$), 2-fold. Our studies illustrated the potential use of SMEDDS for the delivery of hydrophobic compounds, such as atorvastatin calcium by the oral route.

• 폴리머
• /
• 제34권6호
• /
• pp.501-506
• /
• 2010

물에 잘 녹지 않는 고분자량의 키토산을 가수분해하여 수용성을 갖는 저분자량 키토산을 제조하였다. 키토산을 효율적인 유전자 전달체로 개발하기 위하여 항산화제의 일종인 리포산과 결합하여 빗살 형태의 공중합체를 제조하였다. 양친성을 가지는 공중합체는 수용액 상에서 자기조립을 하여 나노입자를 형성하였다. 나노입자의 평균크기는 217.6 nm이었고 유전자와 복합체를 이루었을 때의 평균크기는 170 nm로 나타났다. 새롭게 만들어진 키토산-리포산 공중합체는 낮은 세포독성을 나타내었고 순수한 키토산에 비하여 10배 정도 높은 형질 발현효율을 보여주었다.

• Journal of Pharmaceutical Investigation
• /
• 제22권2호
• /
• pp.105-113
• /
• 1992

To improve the solubility and dissolution rate of trimethoprim (TMP), which is slightly soluble drug, its inclusion complexes were prepared and studied in this experiment. Inclusion complexes of TMP with ${\beta}-cyclodextrin$ and ${\beta}-cyclodextrin$ polymer (CDPS) were prepared according to Fenyvesi method. These were compared with TMP and its physical mixture with CDPS. Water, diluted hydrochloric acid and phosphate buffer solution were used as dissolution media. And accelerated stability test was studied at $50,\;70\;and \;80^{\circ}C$. It was found that solubility and dissolution rate of inclusion complexes were increased in water. Especially, the solubility and dissolution rate of TMP was found to be markedly increased by inclusion complexation with CDPS. In stability test, ${\beta}-cyclodextrin$ inclusion complexes were more or less stable than TMP alone. This tendency was not led in CDPS. Consequently, CDPS was useful in increasing dissolution rate and stability of TMP.

• 폴리머
• /
• 제27권5호
• /
• pp.405-412
• /
• 2003

수용성 고분자인 폴리(비닐 알코올) (PVA)과 키토산에 제 4급 암모늄염을 도입하여 합성한 수용성 키토산 유도체인 N-(2-하이드록시)프로필-3-트리메틸 키토산 클로라이드 (HTCC)를 수용액 상태로 하여 용액 블렌딩하고 이를 캐스팅하여 PVA/HTCC 블렌드 필름을 제조한 후 두 고분자 사이의 혼화성과 블렌드 필름의 특성을 FT-IR, DSC, DMA 및 TGA를 사용하여 검토하였다. HTCC 함량을 50%까지 변화시킨 본 연구의 혼합 범위에서 블렌드 필름들은 모두 투명한 상태를 나타내었으며, T$_{g}$와 T$_{m}$ 이 하나로 나타나 두 고분자 사이에 혼화성이 있음을 확인하였다. 또, HTCC의 우수한 항미생물성 때문에 HTCC가 1%만 포함되더라도 블렌드 필름은 우수한 항미생물성을 나타내었다.

• 폴리머
• /
• 제27권4호
• /
• pp.370-376
• /
• 2003

나노입자의 제조 방법인 개선된 자발적 용매 확산 방법을 이용하여 폴리(DL-락타이드-co-글리콜라이드) 나노입자를 제조하였다. 고분자 용액은 물에 잘 혼합되는 유기 용매인 에탄올과 아세톤의 이종 혼합 용매를 사용하여 제조하였다. 유화제 및 안정제는 우수한 생체적합성을 갖는 PEG-PPG 블록 공중합체를 사용하였다. 최적의 나노입자 제조 조건을 얻기 위하여 나노입자 형성에 영향을 주는 인자들인 안정제의 종류 및 농도, 교반 방법, 물/오일 상의 비, 고분자의 농도 등을 고려하였다. 나노입자 제조 후, 입자의 크기 및 분산도는 광산란 입도 분석기를 이용하여 평가하였다. 제조된 나노입자는 50~200 nm의 크기와 단분산 형태의 크기분포를 보였다. 또한, 유기상과 수용액상에서 이종 혼합 용매와 고분자의 농도에 대한 적당한 조건을 조절함으로써 PLGA 나노입자의 높은 수율과 우수한 물리적 특성을 얻을 수 있었다.

• 대한화학회지
• /
• 제53권5호
• /
• pp.547-552
• /
• 2009

천연고분자물질인 키토산은 생체적합성과 생체활성이 좋은 특성을 가지고 있기 때문에 생체 의료용 재료로 중요하게 다루어지고 있다. 본 연구는 수용성 키토산을 교차결합제인 EGDMA (ethylene glycol dimethacrylate)와 HEMA (2-hydroxyethyl methacrylate), MMA (methylmethacrylate), MA (methacrylic Acid) 그리고 개시제인 AIBN을 사용하여 공중합 하였다. 공중합한 안의료용 재료의 물리적 특성을 측 정한 결과 함수율 24$\sim$59%, 가시광선 투과율 88$\sim$89%, 인장강도 0.1$\sim$2.4 Kgf를 나타내었다. 또한 포도 상구균, 녹농균에 대한 항균성 시험 결과 키토산을 포함하지 않은 고분자에 비해 높은 항균성을 나타내 어 향후 이 공중합체가 고기능성을 가진 안의료용 재료로 사용될 수 있을 것으로 기대된다.

• 폴리머
• /
• 제39권3호
• /
• pp.403-411
• /
• 2015

A series of hydrophobically associating fluorinated amphiphilic polyacrylamide copolymers with remarkably high heat resistance and salt tolerance were synthesized by free radical micellar copolymerization, using acrylamide (AM) and sodium 2-acrylamido-tetradecane sulfonate ($AMC_{14}S$) as amphiphilic monomers, and 2-(perfluorooctyl) ethyl acrylate (PFHEA) as hydrophobic monomer. The structure of the terpolymer was characterized by FTIR, $^1H$ NMR and $^{19}F$ NMR. The solution properties of the terpolymers were investigated in details, and the results showed that the terpolymer solution had strong intermolecular hydrophobic association as the concentration exceeded the critical association concentration 1.5 g/L. The terpolymer solution possessed high surface activity, viscoelasticity, excellent heat resistance, salt tolerance and shearing resistance. The viscosity retention rate of copolymer solution was as high as 59.9% under the condition of fresh wastewater, $85^{\circ}C$ and a 60-days aging test.

• Bulletin of the Korean Chemical Society
• /
• 제32권5호
• /
• pp.1587-1592
• /
• 2011

The aim of the present study was to improve the solubility and bioavailability of a poorly water-soluble drug in human body, using a solid dispersion technique (hot melt extrusion). The solid dispersion was prepared by cooling the hot melt of the drug in the carrier (Vitamin E TPGS and PVP). The dissolution rate of formulation 1 from a novel formulation prepared by solid dispersion technique was equal to release of formulation 6 (40% of eprosartan mesylate is in contrast to teveten$^{(R)}$) within 60 min (Table 1). The oral bioavailability of new eprosartan mesylate tablet having vitamin E TPGS and PVP K29 was tested on rats and dogs. Of the absorption enhancer and polymer tested, vitamin E TPGS and PVP K29, resulted in the greatest increases of AUC in animals (about 2.5-fold increase in rat and dog). When eprosartan mesylate was mixed with the absorption enhancer and polymer in a ratio of 2.94:2:1, vitamin E TPGS and PVP K29 improved eprosartan mesylate bioavailability significantly compared with the conventional immediate release (IR) tablet Teveten$^{(R)}$ (formulation 7). These results show that solid dispersion using vitamin E TPGS and PVP K29 is a promising approach for developing eprosartan mesylate drug products.

• KSBB Journal
• /
• 제26권3호
• /
• pp.217-222
• /
• 2011

Itraconazole is a triazole antifungal agent to inhibit most fungal pathogens. To improve the oral absorption and dissolution of poorly water-soluble itraconazole, microsponge system composed of $Eudragit^{(R)}$ E100 and polyvinyl alcohol(PVA) formulated by quasi-emulsion solvent diffusion method, and its physicochemical properties and pharmacokinetic parameters of itraconazole were studied. The microsponge of itraconazole were discrete free flowing micro sized particles with perforated orange peel like morphology as visualized by scanning electron microscope (SEM). Results showed that the drug loading efficiency, production yield, and particle size of itraconazole microsponge were affected by drug to polymer ratio, the volume of internal phase containing methylene chloride, stirring rate and the concentration of PVA used. Also, the results showed that the dissolution rate of itraconazole from the microsponges was affected by drug to polymer ratio. In other words, the release rate of itraconazole from microsponges was increased from at least 27.43% to 64.72% after 2 h. The kinetics of dissolution mechanism showed that the dissolution data followed Korsmeyer-Peppas model. Therefore, these results suggest that microsponge system can be useful for the oral delivery of itraconazole by manipulating the release profile.